| 常用名 | Remogliflozin etabonate | CAS号 | 442201-24-3 |
|---|---|---|---|
| 价格 | $需询单/100g $需询单/1kg $需询单/100kg $需询单/1000kg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: Remogliflozin etabonate, also known as GSK 189075A or GSK 189075, is a SGLT2 inhibitor under development for the treatment of type 2 diabetes. Remogliflozin etabonate is a pro-drug of remogliflozin. Remogliflozin inhibits the sodium-glucose transport proteins (SGLT), which are responsible for glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. Remogliflozin is selective for SGLT2. 物理化学性质: CAS号:442201-24-3 常用中文名:Remogliflozin etabonate 常用英文名:Remogliflozin etabonate 分子式:C26H38N2O9 分子量:522.58800 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8°C |